LaraƱo, Chamy .
HRN: 27-04-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2025
CEFUROXIME 1.5GM (VIAL)
05/16/2025
05/23/2025
IV
1.5g
Q8
S/p CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes